WallStreetZenWallStreetZen

NASDAQ: BEAM
Beam Therapeutics Inc Stock Ownership - Who owns Beam Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Beam Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Amy SimonChief Medical Officer2025-04-0220,997$17.73
$372.30kSell
John M. EvansCEO2025-04-0130,663$18.35
$562.70kSell
Christine BellonChief Legal Officer2025-04-015,674$18.35
$104.12kSell
Bethany J. CavanaghSVP Finance and Treasurer2025-04-013,015$18.35
$55.33kSell
Amy SimonChief Medical Officer2025-04-019,566$18.35
$175.55kSell
Giuseppe CiaramellaPresident2025-04-017,434$18.35
$136.42kSell
Bethany J. CavanaghSVP Finance and Treasurer2025-02-186,287$35.00
$220.05kSell
Christine BellonChief Legal Officer2025-02-149,492$7.22
$68.53kBuy
Christine BellonChief Legal Officer2025-02-1410,000$34.00
$340.00kSell
Christine BellonChief Legal Officer2025-02-14508$7.22
$3.67kBuy

1 of 3

BEAM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BEAM insiders and whales buy or sell their stock.

BEAM Shareholders

What type of owners hold Beam Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Farallon Capital Management LLC9.87%9,928,111$169.37MInstitution
Vanguard Group Inc8.82%8,871,292$151.34MInstitution
Ark Investment Management LLC8.43%8,480,089$144.67MInstitution
Blackrock Inc8.06%8,102,656$138.23MInstitution
Fmr LLC7.88%7,920,053$135.12MInstitution
Fmr LLC6.00%6,033,868$102.94MInsider
Arch Venture Management LLC4.51%4,540,132$77.45MInstitution
Nikko Asset Management Americas Inc4.25%4,270,020$72.85MInstitution
Sumitomo Mitsui Trust Group Inc4.24%4,266,871$72.79MInstitution
Robert Nelsen3.52%3,535,572$60.32MInsider

1 of 3

BEAM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BEAM84.84%15.16%Net SellingNet Selling
TARS72.75%27.25%Net SellingNet Selling
IMCR95.30%4.33%Net BuyingNet Buying
CNTA90.18%9.82%Net SellingNet Buying
DYN79.63%20.37%Net SellingNet Selling
View Top Biotech Stocks

Beam Therapeutics Stock Ownership FAQ

Who owns Beam Therapeutics?

Beam Therapeutics (NASDAQ: BEAM) is owned by 100.78% institutional shareholders, 18.01% Beam Therapeutics insiders, and 0.00% retail investors. Fmr LLC is the largest individual Beam Therapeutics shareholder, owning 6.03M shares representing 6.00% of the company. Fmr LLC's Beam Therapeutics shares are currently valued at $102.94M.

If you're new to stock investing, here's how to buy Beam Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.